Literature DB >> 20851224

Metabolism and pharmacokinetics of contraceptive steroids in obese women: a review.

Alison B Edelman1, Ganesh Cherala, Frank Z Stanczyk.   

Abstract

The effect of obesity on drug metabolism and pharmacokinetics is poorly understood, and this is particularly true in regard to contraceptive steroids. This article will review the known and theoretical physiologic and pharmacologic interactions between obesity and contraceptive steroids.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20851224     DOI： 10.1016/j.contraception.2010.04.016

Source DB:  PubMed          Journal:  Contraception        ISSN： 0010-7824            Impact factor:   3.375


  28 in total

1.  Healthcare Provider Attitudes Regarding Contraception for Women with Obesity.

Authors:  Tara C Jatlaoui; Lauren B Zapata; Kathryn M Curtis; Suzanne G Folger; Polly A Marchbanks; Michele G Mandel; Denise J Jamieson
Journal:  J Womens Health (Larchmt)       Date:  2017-01-31       Impact factor: 2.681

2.  Simultaneous quantitation of multiple contraceptive hormones in human serum by LC-MS/MS.

Authors:  Steven W Blue; Andrea J Winchell; Amy V Kaucher; Rachel A Lieberman; Christopher T Gilles; Maria N Pyra; Renee Heffron; Xuanlin Hou; Robert W Coombs; Kavita Nanda; Nicole L Davis; Athena P Kourtis; Joshua T Herbeck; Jared M Baeten; Jairam R Lingappa; David W Erikson
Journal:  Contraception       Date:  2018-01-31       Impact factor: 3.375

Review 3.  Obesity and contraception.

Authors:  Sheila K Mody; Michelle Han
Journal:  Clin Obstet Gynecol       Date:  2014-09       Impact factor: 2.190

Review 4.  Pharmacokinetic and pharmacodynamic drug interactions between antiretrovirals and oral contraceptives.

Authors:  Victoria Tittle; Lauren Bull; Marta Boffito; Nneka Nwokolo
Journal:  Clin Pharmacokinet       Date:  2015-01       Impact factor: 6.447

Review 5.  Impact of obesity on drug metabolism and elimination in adults and children.

Authors:  Margreke J E Brill; Jeroen Diepstraten; Anne van Rongen; Simone van Kralingen; John N van den Anker; Catherijne A J Knibbe
Journal:  Clin Pharmacokinet       Date:  2012-05-01       Impact factor: 6.447

Review 6.  Drug metabolism alterations in nonalcoholic fatty liver disease.

Authors:  Matthew D Merrell; Nathan J Cherrington
Journal:  Drug Metab Rev       Date:  2011-05-25       Impact factor: 4.518

7.  Levonorgestrel butanoate intramuscular injection does not reliably suppress ovulation for 90 days in obese and normal-BMI women: a pilot study.

Authors:  Alison B Edelman; Ganesh Cherala; Hong Li; Francis Pau; Diana L Blithe; Jeffrey T Jensen
Journal:  Contraception       Date:  2016-07-27       Impact factor: 3.375

8.  Effects of ritonavir-boosted protease inhibitors on combined oral contraceptive pharmacokinetics and pharmacodynamics in HIV-positive women.

Authors:  Teresa Barcellos; Melissa Natavio; Frank Z Stanczyk; Dandan Luo; William J Jusko; Nicole M Bender
Journal:  Contraception       Date:  2019-06-10       Impact factor: 3.375

Review 9.  Obesity and hormonal contraceptive efficacy.

Authors:  Jennifer A Robinson; Anne E Burke
Journal:  Womens Health (Lond)       Date:  2013-09

Review 10.  Oral Contraceptives after Bariatric Surgery.

Authors:  Joël Schlatter
Journal:  Obes Facts       Date:  2017-04-22       Impact factor: 3.942
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.